Aspira Women's Health Inc.
AWHL- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000926617
No open-market purchases or sales by Aspira Women's Health Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Aspira Women's Health Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +2 vs. Q2 2023
- Shares held
- 657.8K
- +127.9K (+24.1%) vs. Q2 2023
- Total value
- $3.53M
- +$1.77M (+101.0%) vs. Q2 2023
- New holders
- 4
- 9 more added
- Sold out
- 2
- 7 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AWHL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $392 |
| Q2 2025 | 2 | $15.7K |
| Q1 2025 | 25 | $81.0K |
| Q4 2024 | 26 | $1.03M |
| Q3 2024 | 25 | $1.91M |
| Q2 2024 | 26 | $2.08M |
| Q1 2024 | 23 | $6.15M |
| Q4 2023 | 24 | $2.92M |
| Q3 2023 | 24 | $3.53M |
| Q2 2023 | 22 | $1.75M |
| Q1 2023 | 45 | $3.25M |
| Q4 2022 | 47 | $3.24M |
| Q3 2022 | 58 | $4.46M |
| Q2 2022 | 72 | $7.02M |
| Q1 2022 | 92 | $22.9M |
| Q4 2021 | 98 | $50.9M |
| Q3 2021 | 92 | $97.0M |
| Q2 2021 | 95 | $174.1M |
| Q1 2021 | 97 | $211.5M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Aspira Women's Health Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 182,845 | $980.0K | 0.00% | +1,215+0.7% | Added |
| National Asset Management, Inc. | 125,374 | $672.0K | 0.02% | +35,177+39.0% | Added |
| BlackRock Inc. | 63,169 | $338.6K | 0.00% | −2,955−4.5% | Reduced |
| Geode Capital Management, LLC | 51,758 | $277.5K | 0.00% | +11,912+29.9% | Added |
| Perkins Capital Management Inc | 50,000 | $268.0K | 0.27% | +50,000 | New |
| TownSquare Capital, LLC | 36,809 | $197.3K | 0.00% | −4,878−11.7% | Reduced |
| Quantum Private Wealth, LLC | 28,368 | $152.1K | 0.07% | +60.0% | Added |
| Northeast Financial Consultants Inc | 23,436 | $125.6K | 0.01% | +23,436 | New |
| Bank of America Corp | 17,875 | $95.8K | 0.00% | +17,809+26,983.3% | Added |
| State Street Corp | 16,049 | $86.0K | 0.00% | 00.0% | Unchanged |
| M&T Bank Corp | 14,999 | $80.4K | 0.00% | −1,666−10.0% | Reduced |
| Susquehanna International Group, LLP | 12,156 | $65.2K | 0.00% | +12,156 | New |
| Millennium Management LLC | 11,504 | $61.7K | 0.00% | −15,364−57.2% | Reduced |
| Northern Trust Corp | 11,002 | $59.0K | 0.00% | +11,002 | New |
| Advisor Group Holdings, Inc. | 4,894 | $26.2K | 0.00% | +758+18.3% | Added |
| Morgan Stanley | 2,107 | $11.3K | 0.00% | −5,991−74.0% | Reduced |
| JPMorgan Chase & Co | 2,070 | $11.1K | 0.00% | +6+0.3% | Added |
| Castleview Partners, LLC | 1,316 | $7.05K | 0.01% | 00.0% | Unchanged |
| Operose Advisors LLC | 1,000 | $5.36K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 420 | $2.25K | 0.00% | −2,926−87.4% | Reduced |
| UBS Group AG | 381 | $2.04K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 155 | $831 | 0.00% | +121+355.9% | Added |
| Group One Trading, L.P. | 119 | $638 | 0.00% | −97−44.9% | Reduced |
| Barclays PLC | 30 | $160 | 0.00% | +15+100.0% | Added |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,546−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −313−100.0% | Sold out |